MJ

Active Director Director DIN 09257914
DIN 09257914 First appointment Jul 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Mamta Jha

Data last updated:

Mamta Jha is a Director at Triroz Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Triroz Pharmaceuticals Private Limited reported revenue of ₹7.4 Lakh (FY 2024).

DIN 09257914
Primary Designation Director
Industry Chemicals
First Appointment 28 Jul 2021
Oldest Company Age 5 yrs
Largest company Triroz Pharmaceuticals Private Limited · ₹7.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jul 20212021₹7.4 Lakh (FY 2024)Active

Board colleagues of Mamta Jha

NameDINCompanyDesignation
Archana Kumari09257915Triroz Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Triroz Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mamta Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mamta Jha

Mamta Jha currently holds 1 directorship: Triroz Pharmaceuticals Private Limited (Director, since 28 Jul 2021, revenue ₹7.4 Lakh (FY 2024)).

Mamta Jha was first appointed on 28 Jul 2021 as Director at Triroz Pharmaceuticals Private Limited.

The current boards of Mamta Jha's companies include Archana Kumari (Triroz Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available